Want to join the conversation?
$ANGO's 1Q17 GM declined 70 BP YoverY, driven by pricing pressure and the mix of products sold. However, the company is confident of increasing GM across its operating businesses going forward. The company spent over $400,000 in CapEx in the quarter and at the end of 1Q17, $ANGO had $37.4MM in cash and cash equivalents and gross debt of $118.9MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.